Base of biosensors

Fluofarma has developed proprietary biosensors which can report on specific molecular events involved in a range of physiopathological processes such as cancer, neurodegenerative disease and aging.

Principles

Fluofarma's probes, based on fluorescent fusion proteins, are reporter substrates for specific cellular events. The biosensing proteins are stably expressed in human cell lines and convert a biological response into a fluorescent signal which is measured by flow cytometry. Hence, fluorescent changes in living cells expressing a specific biosensor are linked to the corresponding, specific biological event.

Applications

Cell lines expressing one of Fluofarma’s biosensors enable screening which focuses on a specific biological event. Moreover, our biosensors can help you understand the compound’s mechanism of action.

 

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal Biochimica et Biophysica Acta - Molecular Cell Research.

    Read more [+]

  • IFSCC 2008

    Fluofarma will be attending IFSCC 2008, in Barcelona, from October 6th to 9th.

    Read more [+]

  • INVITOX 2008

    Fluofarma will be attending the INVITOX 2008 meeting, in Stockholm from September 25th to 28th.

    Read more [+]

  • EuroBio 2008

    Fluofarma will be attending EuroBio 2008, in Paris from October 7th to 9th.

    Read more [+]

  • SMi's Cell-Based Assays 2008

    Fluofarma will be attending SMi's Cell-Based Assays conference, in London from November 19th to 20th.

    Read more [+]

  • GDDI Forum 2009

    Fluofarma will be attending Global Discovery & Development Innovation Forum 2009, in London, from March 2nd to 3rd.

    Read more [+]

FOCUS: Anticancer drugs profiling
Fluofarma has developed DCffer® method, a powerful approach to compare and profile your anti-cancer drugs. Read more [+]